Unknown

Dataset Information

0

Akt and CHIP coregulate tau degradation through coordinated interactions.


ABSTRACT: A hallmark of the pathology of Alzheimer's disease is the accumulation of the microtubule-associated protein tau into fibrillar aggregates. Recent studies suggest that they accumulate because cytosolic chaperones fail to clear abnormally phosphorylated tau, preserving a pool of toxic tau intermediates within the neuron. We describe a mechanism for tau clearance involving a major cellular kinase, Akt. During stress, Akt is ubiquitinated and degraded by the tau ubiquitin ligase CHIP, and this largely depends on the Hsp90 complex. Akt also prevents CHIP-induced tau ubiquitination and its subsequent degradation, either by regulating the Hsp90/CHIP complex directly or by competing as a client protein with tau for binding. Akt levels tightly regulate the expression of CHIP, such that, as Akt levels are suppressed, CHIP levels also decrease, suggesting a potential stress response feedback mechanism between ligase and kinase activity. We also show that Akt and the microtubule affinity-regulating kinase 2 (PAR1/MARK2), a known tau kinase, interact directly. Akt enhances the activity of PAR1 to promote tau hyperphosphorylation at S262/S356, a tau species that is not recognized by the CHIP/Hsp90 complex. Moreover, Akt1 knockout mice have reduced levels of tau phosphorylated at PAR1/MARK2 consensus sites. Hence, Akt serves as a major regulator of tau biology by manipulating both tau kinases and protein quality control, providing a link to several common pathways that have demonstrated dysfunction in Alzheimer's disease.

PROVIDER: S-EPMC2265134 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC1482526 | BioStudies
| S-EPMC3089541 | BioStudies
| S-EPMC5937037 | BioStudies
2005-01-01 | S-EPMC1196348 | BioStudies
| S-EPMC6890249 | BioStudies
| S-EPMC6672561 | BioStudies
| S-EPMC204455 | BioStudies
| S-EPMC3373241 | BioStudies
| S-EPMC3248009 | BioStudies
| S-EPMC7065254 | BioStudies